# Informatics Evaluation (STARE-HI Framework)
STARE-HI is a 35-item checklist used by researchers to report on health informatics evaluations.

* **Item 3: Healthcare Context & Problem:**
Clinical safety data is currently fragmented across across unstructured FDA metadata and specialized population guidelines (Beers Criteria, STOPP/START). This fragmentation imposes a high cognitive load on pharmacists and clinicians, requiring manual cross-referencing that is prone to human error.
CILE addresses this by consolidating these vectors by prioritizing high-alert population intercepts in cross-referencing on Beers Criteria, FDA safety alerts, and PGx markers into a single, logic-driven query.

* **Item 5: System Details & Architecture:**
The engine is designed as a modular tool:
 - Normalization: Resolution of brand/trade names to RxNorm Concept Unique Identifiers (RxCUIs) to ensure chemical moiety integrity.
 - Extraction: Heuristic-based polling from localized database, where if not found, another request from the openFDA discovery API using prioritized fallback loops for safety metadata.
 - Logic: Deterministic matching requests on localized and real-time openFDA resources.
 - Interoperability: Dual-export generation of PDF consultation report and HL7 FHIR-standardized JSON files.

* **Item 12: Outcome Measures & Validation:**
    - Validation Method: CILE was tested across clinical cases, including monotherapies, safe regimens, and high-risk polypharmacy for different age groups and sensitive populations. Check `validation_cases` for more!
    - Core Metrics:
        1. **Population Sensitivity:** Mathematical ratification of strict FDA demographic boundaries (e.g. pediatric strictly <18 years, mapping to neonate/infant/child/adolescent sub-brackets).
        2. **Genomic Extraction Accuracy:** Consistent identification of PGx targets and teratogenic markers isolated from raw text payloads.
        3. **Alert Specificity:** Deduplication of federal warnings and suppression of false-positive alert fatigue in verified safe regimens.